Frier Levitt Life Sciences attorneys, Dae Y. Lee, Pharm.D., Esq., CPBS and Jonathan Levitt, Esq. co-authored an article titled: “The Consolidated Appropriations Act and PBM Transparency” in Pharmaceutical Commerce on May 12, 2023. In this... Read More
Frier Levitt is happy to announce a successful result on behalf of an urgent care center client in a county-based Department of Health (“DOH”) Hearing matter. The urgent care center was facing significant civil penalties of over $30,000 for... Read More
Arielle T. Miliambro, a Partner in Frier Levitt’s Healthcare and Life Sciences Departments, has been selected as a recipient of the 40 Under 40 in Cancer Award sponsored by The Association for Value-Based Cancer Care (AVBCC), The National... Read More
Pine Brook, NJ (May 15, 2023) – Frier Levitt is pleased to announce that 16 firm attorneys have been selected to the 2023 New Jersey Super Lawyers and Rising Stars Lists. Each year, no more than 5 percent of attorneys in the state are selected... Read More
Frier Levitt Co-Founding Partner Jonathan Levitt was recently invited to testify before the U.S. Senate Committee on Finance during its hearing titled “Pharmacy Benefit Managers and the Prescription Drug Supply Chain: Impact on Patients and... Read More
Frier Levitt recently helped a New York based pharmacy overturn a network enrollment denial by a major Pharmacy Benefit Manager (“PBM”). The PBM rejected the pharmacy’s enrollment application due to allegations of “common association or... Read More
Fraud is a persistent issue in the history of U.S. healthcare. However, with the government’s decreased oversight and the implementation of telehealth billing codes and diagnostic abilities during the COVID-19 pandemic, new opportunities for... Read More
Press Release – New York/New Jersey, April 26, 2023 – Frier Levitt is pleased to announce that Matthew Modafferi has joined the firm as a partner in the Litigation Team. Mr. Modafferi has practiced for more than 13 years and brings substantial... Read More
In the April/May edition of Podiatry Management, Frier Levitt attorney and licensed podiatrist Lawrence F. Kobak sheds light on the critical importance of understanding subpoenas for podiatrists. The article covers the different types of subpoenas... Read More
In November of 2022, the CDC made available their “new and improved” guideline concerning the use of opioids and pain, stating that, since its original guideline on this topic, new evidence has come to the fore. Additionally, it addresses... Read More
